Alazhar Colombowala

Alazhar Colombowala

Auto-generated profile, based on publicly available information

Alazhar Colombowala

Cambridge Institute for Medical Research, University of Cambridge, Keith Peters Building, Hills Road, Cambridge, CB2 0XY, UK

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 February 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
ESEleanor Silvester
Eleanor Silvester
CBCarla Briggs
Carla Briggs
ACAlazhar Colombowala
Alazhar Colombowala
AKAnna Kuroshchenkova
Anna Kuroshchenkova
VFVictor Flores
Victor Flores
JRJulian C. Rayner
Julian C. Rayner
To maintain infection in the human bloodstream, Plasmodium falciparum parasites undergo repeated cycles of invasion of and multiplication inside red blood cells (RBCs). Two protein families, the Erythrocyte binding-like (EBA) and Reticulocyte binding-like (Rh) proteins, are known to play a key role in invasion, mediating early stages of attachment of the P. falciparum merozoite to the host RBC. There is a degree of redundancy within these families, such that disrupting the function of individual EBA/Rh proteins in vitro is not sufficient to prevent invasion. By employing a novel approach to disrupt multiple EBA and Rh genes in combination, we systematically assessed functional interdependency across these families for the first time. This analysis, and further characterisation of mutant parasites, revealed that disruption of some pairs of EBA/Rh ligands significantly impacted P. falciparum invasion, whereas others did not. Disruption of PfEBA175 in combination with either PfRh2b or PfRh4 significantly reduced parasite multiplication in vitro , indicating that the remaining EBA/Rh proteins could not fully compensate for the absence of these three key invasion ligands. PfEBA175, PfRh2b and PfRh4 may therefore represent a critical nexus of the parasite invasion machinery, and combinatorial approaches that target these specific ligands could be a beneficial therapeutic approach.